4//SEC Filing
Hessekiel Jeffrey 4
Accession 0000939767-24-000131
CIK 0000939767other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 7:07 PM ET
Size
10.3 KB
Accession
0000939767-24-000131
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Hessekiel Jeffrey
EVP and General Counsel
Transactions
- Sale
Common Stock
2024-08-26$25.79/sh−20,000$515,800→ 630,325 total - Exercise/Conversion
Common Stock
2024-08-26$24.41/sh+20,000$488,200→ 650,325 total - Exercise/Conversion
Option (right to buy)
2024-08-26−20,000→ 0 totalExercise: $24.41From: 2018-10-03Exp: 2024-10-02→ Common Stock (20,000 underlying)
Holdings
- 999(indirect: By 401(k))
Common Stock
Footnotes (5)
- [F1]Includes 236,022 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 29, 2024.
- [F3]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.68 to $25.87. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
- [F4]Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 25, 2024.
- [F5]The option, representing the right to purchase a total of 100,000 shares of Exelixis, Inc. common stock became fully exercisable on October 3, 2021.
Documents
Issuer
EXELIXIS, INC.
CIK 0000939767
Entity typeother
Related Parties
1- filerCIK 0001599803
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 7:07 PM ET
- Size
- 10.3 KB